X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6029) 6029
Publication (698) 698
Book Review (123) 123
Book Chapter (53) 53
Newsletter (41) 41
Conference Proceeding (8) 8
Magazine Article (7) 7
Dissertation (3) 3
Book / eBook (2) 2
Paper (2) 2
Data Set (1) 1
Newspaper Article (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3983) 3983
animals (2732) 2732
index medicus (2654) 2654
male (1748) 1748
female (1422) 1422
mice (972) 972
peripheral vascular disease (746) 746
middle aged (741) 741
hematology (739) 739
rats (713) 713
inflammation (652) 652
tissue-plasminogen activator (637) 637
stroke (598) 598
aged (591) 591
expression (589) 589
cell biology (581) 581
tissue plasminogen activator (574) 574
neurosciences (569) 569
adult (567) 567
biochemistry & molecular biology (560) 560
cells, cultured (544) 544
research (512) 512
fibrinolysis (474) 474
pharmacology & pharmacy (461) 461
tissue plasminogen activator - therapeutic use (455) 455
disease models, animal (447) 447
thrombolytic therapy (446) 446
risk factors (424) 424
thrombolysis (423) 423
proteins (422) 422
analysis (416) 416
cardiac & cardiovascular systems (413) 413
tissue plasminogen activator - metabolism (413) 413
fibrinolytic agents - therapeutic use (406) 406
time factors (406) 406
obesity (396) 396
gene expression (394) 394
endocrinology & metabolism (390) 390
tissue plasminogen activator - antagonists & inhibitors (388) 388
physiological aspects (368) 368
care and treatment (366) 366
health aspects (366) 366
oncology (364) 364
signal transduction (361) 361
article (358) 358
tissue-plasminogen-activator (355) 355
tissue factor (353) 353
clinical neurology (348) 348
treatment outcome (347) 347
thrombosis (344) 344
medicine & public health (334) 334
medicine (330) 330
plasminogen-activator (321) 321
review (320) 320
ischemia (319) 319
research article (313) 313
gene-expression (301) 301
mice, inbred c57bl (296) 296
rodents (293) 293
cancer (288) 288
in-vitro (286) 286
multidisciplinary sciences (286) 286
dose-response relationship, drug (285) 285
cytokines (282) 282
medicine, research & experimental (280) 280
insulin-resistance (272) 272
angiogenesis (271) 271
acute myocardial-infarction (267) 267
adipose-tissue (267) 267
in-vivo (265) 265
stroke - drug therapy (264) 264
therapy (262) 262
surgery (258) 258
physiology (254) 254
activation (253) 253
immunology (253) 253
fibrinolysis - drug effects (246) 246
rats, sprague-dawley (246) 246
neurology (245) 245
endothelial-cells (244) 244
apoptosis (240) 240
cells (237) 237
tissue plasminogen activator - pharmacology (237) 237
tissue (235) 235
insulin resistance (230) 230
drug therapy, combination (229) 229
mortality (228) 228
thrombin (228) 228
tissue plasminogen activator - administration & dosage (226) 226
matrix metalloproteinases (220) 220
acute ischemic-stroke (219) 219
brain (219) 219
myocardial infarction - drug therapy (219) 219
rna, messenger - metabolism (217) 217
atherosclerosis (212) 212
drug therapy (212) 212
necrosis-factor-alpha (211) 211
diabetes (209) 209
inhibition (209) 209
plasminogen-activator inhibitor-1 (209) 209
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6035) 6035
Japanese (34) 34
German (23) 23
French (19) 19
Russian (11) 11
Spanish (10) 10
Chinese (9) 9
Polish (4) 4
Dutch (2) 2
Korean (2) 2
Czech (1) 1
Finnish (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain, ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3251 - 3264
The neurovascular unit provides a dynamic interface between the circulation and central nervous system. Disruption of neurovascular integrity occurs in... 
traumatic brain injury | matrix metalloproteinase-3 | plasminogen activator inhibitor-1 | tissue plasminogen activator | neurovascular unit | MULTIPLE-SCLEROSIS LESIONS | RECEPTOR-RELATED PROTEIN | TPA | FOCAL CEREBRAL-ISCHEMIA | BARRIER BREAKDOWN | NEUROSCIENCES | CLINICAL NEUROLOGY | STROKE | MATRIX METALLOPROTEINASES | CENTRAL-NERVOUS-SYSTEM | EXPRESSION | BLOOD | Capillary Permeability - physiology | Tissue Plasminogen Activator - metabolism | Brain Injuries - drug therapy | Humans | Middle Aged | Injections, Intraventricular | Capillary Permeability - drug effects | Male | Brain Injuries - metabolism | Brain Injuries - physiopathology | Plasminogen Activator Inhibitor 1 - physiology | Matrix Metalloproteinase Inhibitors - therapeutic use | Brain - metabolism | Dose-Response Relationship, Drug | Brain - blood supply | Tissue Plasminogen Activator - antagonists & inhibitors | Plasminogen Activator Inhibitor 1 - metabolism | Aged, 80 and over | Recovery of Function - physiology | Adult | Disease Models, Animal | Albumins - metabolism | Mice, Inbred C57BL | Plasminogen Activator Inhibitor 1 - administration & dosage | Tissue Plasminogen Activator - administration & dosage | Tissue Plasminogen Activator - physiology | Animals | Brain Injuries - cerebrospinal fluid | Aged | Mice | Matrix Metalloproteinases - metabolism | Stroke | Central nervous system | Membrane permeability | Albumin | Homeostasis | Cerebrospinal fluid | Matrix metalloproteinase | Permeability | Trauma | Plasmin | t-Plasminogen activator | lipoprotein receptors | neuroserpin | plasminogen | Proteolysis | Plasma membranes | Chromium | Serine proteinase | Brain injury | Original
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 10/2016, Volume 20, Issue 10, pp. 1851 - 1860
Journal Article
Circulation, ISSN 0009-7322, 03/2017, Volume 135, Issue 11, pp. 1024 - 1035
Journal Article
Nature Medicine, ISSN 1078-8956, 07/2008, Volume 14, Issue 7, pp. 731 - 737
Journal Article
Annals of Emergency Medicine, ISSN 0196-0644, 2016, Volume 68, Issue 3, pp. 345 - 348
Journal Article
Journal Article
ACS Chemical Biology, ISSN 1554-8929, 06/2015, Volume 10, Issue 6, pp. 1521 - 1534
The urokinase receptor (uPAR) is a GPI-anchored cell surface receptor that is at the center of an intricate network of protein-protein interactions. Its... 
Focal Adhesion Kinase 1 - genetics | Integrin alphaVbeta3 - chemistry | Small Molecule Libraries - pharmacology | Urokinase-Type Plasminogen Activator - antagonists & inhibitors | Humans | Integrins - genetics | Vitronectin - genetics | Integrins - metabolism | Vitronectin - antagonists & inhibitors | Integrin alphaVbeta3 - metabolism | Thermodynamics | Integrin alphaVbeta3 - genetics | HEK293 Cells | Urokinase-Type Plasminogen Activator - chemistry | Binding Sites | Focal Adhesion Kinase 1 - metabolism | Serine Proteinase Inhibitors - pharmacology | Integrin alphaVbeta3 - antagonists & inhibitors | Binding, Competitive | Cell Survival - drug effects | Receptors, Urokinase Plasminogen Activator - chemistry | Serine Proteinase Inhibitors - chemical synthesis | Signal Transduction | Gene Expression Regulation | Small Molecule Libraries - chemical synthesis | Urokinase-Type Plasminogen Activator - genetics | Cell Adhesion - drug effects | Vitronectin - metabolism | Receptors, Urokinase Plasminogen Activator - antagonists & inhibitors | Peptides - pharmacology | Receptors, Urokinase Plasminogen Activator - metabolism | Cell Movement - drug effects | Pyrroles - pharmacology | Pyrroles - chemical synthesis | Urokinase-Type Plasminogen Activator - metabolism | Vitronectin - chemistry | Cell Line, Tumor | Protein Binding | Receptors, Urokinase Plasminogen Activator - genetics | Kinetics | rac1 GTP-Binding Protein - metabolism | Receptor Cross-Talk - drug effects | rac1 GTP-Binding Protein - genetics
Journal Article
Journal Article